Joseph Todisco - 17 May 2023 Form 4/A - Amendment Insider Report for CorMedix Inc. (CRMD)

Role
Chief Executive Officer, Director
Signature
/s/ Joseph Todisco
Issuer symbol
CRMD
Transactions as of
17 May 2023
Net transactions value
+$22,900
Form type
4/A - Amendment
Filing time
18 May 2023, 16:49:19 UTC
Date Of Original Report
17 May 2023
Previous filing
12 May 2023
Next filing
08 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Purchase $22,900 +5,000 +2.4% $4.58 209,726 17 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 17, 2023, the reporting person filed a Form 4 which inadvertently included Transaction Code "A". The original Form 4 should have indicated Transaction Code "P". The reporting person has filed this amendment to restate the transaction with the correct Transaction Code.